HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Georgiana Nitulescu Selected Research

buclizine (Bucladin-S)

12/2021Identifying FAAH Inhibitors as New Therapeutic Options for the Treatment of Chronic Pain through Drug Repurposing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Georgiana Nitulescu Research Topics

Disease

2Infections
08/2020 - 10/2017
2Neoplasms (Cancer)
01/2020 - 12/2018
1Chronic Pain
12/2021
1Community-Acquired Infections
11/2021
1Heart Diseases (Heart Disease)
12/2018

Drug/Important Bio-Agent (IBA)

2Pharmaceutical PreparationsIBA
12/2021 - 10/2017
1revefenacinIBA
12/2021
1EnzymesIBA
12/2021
1EndocannabinoidsIBA
12/2021
1repaglinide (Prandin)FDA Link
12/2021
1montelukast (Singulair)FDA Link
12/2021
1fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA
12/2021
1Raloxifene Hydrochloride (Evista)FDA Link
12/2021
1buclizine (Bucladin-S)FDA Link
12/2021
1Anti-Bacterial Agents (Antibiotics)IBA
11/2021
1sortase AIBA
10/2017
1Anti-Infective Agents (Microbicides)IBA
10/2017

Therapy/Procedure

4Therapeutics
12/2021 - 12/2018